Dynamiclear is a powerful Anti-viral solution that gives users Rapid Relief in One Application. Each vial contains 100 single applications making it abundant value. It also comes with a 6 month “no hassle” money back guaranteed to insure you results.

Product Ingredients Include: Hypericum perforatum, Calendula officinalis, Cupric sulfate pentahydrate, Vegetable Derived Glycerol, Aloe vera barbadensis, Naturally Sourced Vitamin E, Purified Water.

Dynamiclear has taken another evolutionary step which offers users many new benefits designed to improve customer satisfaction.

Two complaints that we received in the past about Dynamiclear were:

1. The solution stung a little too much for some people when applied

2. Mixing the solution before application was awkward

We listened to our customers feedback and as a result we have worked with our chemists to enhance the Dynamiclear formulation to include a moisturizing agent (to minimize stinging and improve recovery) and we developed a premixed formula for direct application (no mix).

On top of these improvements we greatly improved the packaging look and feel and product delivery system.

If you have tried Dynamiclear I would love your feedback.

Can you give your partner herpes by french kissing?

Yes and No.

Yes, it is possible to give your partner herpes by french kissing if you have oral herpes.

No, it is not possible to give your partner herpes by french kissing if you do not have oral herpes.

If you have a history of cold sores or fever blisters then it’s probably very likely that you have oral herpes. If you’re not sure then you should see your doctor for proper herpes testing.

This vaccine requirement stems from the 1996 Immigration and Nationality Act, which mandates that prior to being granted permanent resident status, immigrants must receive all vaccines recommended by the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP). In 2008, however, the U.S. Citizenship and Immigration Services (USCIS) updated the list of vaccines required of immigrants to include HPV, a move criticized by a number of advocacy groups who say the mandate places undue burden on those seeking to enter the U.S., and in particular, to women and girls.

Some organizations and advocate groups that focus on immigrant rights and women’s health have questioned the necessity of forcing individuals to receive the vaccine considering that HPV isn’t communicable in public settings. Of the 14 required vaccines, 13 of which aim to prevent infectious diseases considered highly contagious, Gardasil alone targets a sexually transmissible virus. Another worry is that cost may pose unfair financial burden placed on women, possibly acting as a significant financial barrier to seeking citizenship (the vaccine costs $360, plus clinic fees).

Simone protests the HPV vaccine for several reasons; her story reported by abcnews.com. As a devout Christian, Simone has taken a virginity pledge and doesn’t understand she why she should be required to take the vaccine when she doesn’t believe herself to be at risk. Her guardian and paternal grandmother, whom Simone calls “Nanny,” was also upset by this mandate and filed a waiver to the U.S. Citizenship and Immigration Services on moral and religious grounds but was rejected. Now facing the possibility of being separated from her Nanny, with only 30 days to appeal the decision before she must reapply as an adult (which requires a five year wait to become eligible for citizenship), Simone questions why none of her American classmates were required to take the HPV vaccine. Simone’s Nanny claims the issue is not simply about religion, and instead highlights their desire to have the same rights of any U.S. citizen.

Deborah Arrindell, ASHA’s vice-president of health policy, says “This vaccine has enormous potential to protect women’s health, no one’s debating that. What’s troubling is the requirement extends only to immigrants, and doesn’t apply to U.S. citizens. One has to question just how much public health is advanced by requiring the vaccine for a such a narrow segment of the population.” Jon Abramson, chairman of the CDC’s Advisory Committee for Immunization Practices when the body recommended the vaccine for U.S. citizens last year, further purports that this policy is “not a good idea.”

There are some indications, however, that the HPV vaccine requirement may be reconsidered. Within the month CDC is expected to release new criteria to determine which vaccines should be mandated for U.S. immigrants. Whether this new criteria will affect Simone Davis’ situation, or the lives of other female immigrants, has yet to seen.

HPV and Cervical Cancer Prevention, HPV Vaccines

More HPV Information

You can also talk about HPV here

Researchers optimistic, but questions remain

On Thursday, September 24, 2009, The Surgeon General of the U.S. Army released results from the Thai Phase III HIV vaccine study that demonstrated modest results in preventing HIV infection among participants in the clinical trial. The study found the vaccine regimen to be safe and 31 percent effective in preventing HIV infection.

The potential breakthrough comes after several failed vaccine trials; many scientists believed an HIV vaccine might not be possible. For the first time, however, the Thai Phase III study used the combination of two vaccines, Sanofi Pasteur’s ALVAC vaccine and the AIDSVAX B/E vaccine, developed by Vaxgen Inc. and licensed to the nonprofit Global Solutions for Infectious Diseases (GSID) in 2008. The research was sponsored jointly by the U.S. Army and the National Institute of Allergy and Infectious Diseases (NIAID), along with Sanofi Pasteur and GSID.

The study, conducted in two Thai provinces, began in October 2003 and involved approximately 16,402 HIV-negative subjects ages 18-30 at various levels of risk for HIV infection. Trial participants were evenly divided into groups and received either the vaccine or placebo upon enrollment in the study and again after 1 month, 3 months, and 6 months. Participants were counseled on HIV risk reduction strategies and tested for the virus twice a year for three years. Among the 8,197 subjects who received the combination of vaccines, 51 contracted HIV during the study. This compares to 74 of the 8,198 participants in the placebo group who became infected with the virus. Those who became HIV-positive during the study have been offered treatment at no cost.

In a press release, Anthony S Fauci, M.D. and Director of the National Institute of Allergy and Infectious Diseases, acknowledges these new findings as “an important step forward in HIV vaccine research,” but cautions that “additional research is needed to better understand how this vaccine regimen reduced the risk of HIV infection.”

The United Nations Joint Programme on HIV/AIDS estimates that 7,000 people worldwide are newly infected with HIV everyday; 2 million people died of AIDS in 2007. There is much to consider regarding future HIV vaccine research. Yet, after more than two decades, the search for a safe, effective vaccine that protects against HIV infection has made an encouraging advance.

HIV AND AIDS Questions & Answers

More HIV Information

You can also talk about HIV here

just want to say thank you. you are very cool. and very brave. and I totally appreciate your approach and content. you give hope and needed info to people who are feeling so down!! keep up the good work!! – Kim

See what others are saying about Yoshi2me.com

Getting the H1N1 Vaccine?

I am having my doubts on the H1N1 vaccine. I don’t think our family will be participating in it this time. We are definitely going to get the regular flu shot.

You Are Beautiful Inside And Out

Positive and encouraging is what it’s all about. :]

The Bathroom And Herpes

This topic comes up A LOT.

I think the thing that people need to remember is that you are not going to contract herpes from a toilet seat. As far as sharing towels go – why would you share a towel with someone anyway?

Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.

“These new findings represent an important step forward in HIV vaccine research,” says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, which provided major funding and other support for the study.

“For the first time, an investigational HIV vaccine has demonstrated some ability to prevent HIV infection among vaccinated individuals. Additional research is needed to better understand how this vaccine regimen reduced the risk of HIV infection, but certainly this is an encouraging advance for the HIV vaccine field.”

For more information – Talk about clinical trials and vaccine research – Talk about HIV – More HIV Information

HCV infection is a major cause of liver damage and progresses more rapidly in HIV-infected people. Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), are enrolling volunteers for a clinical trial to evaluate a new treatment that may suppress the HCV virus in HIV/HCV co-infected patients.

The clinical trial is being conducted at the NIH in Bethesda, MD.

For more information – HIV Information – Talk About HIV – HEP Information – Talk About HEP

NIAID News gave me permission to share this information with you. I want all of my readers to know what is going on with HIV. Thanks so much for reading my blog.

The study, called Vaginal and Oral Interventions to Control the Epidemic (VOICE) or MTN-003, will involve up to 5,000 HIV-uninfected women at risk for HIV infection in four African countries. The trial will test the safety and efficacy of two different HIV prevention strategies: an investigational microbicide gel containing the antiretroviral drug tenofovir, and oral tablets containing tenofovir or a combination of tenofovir and emtricitabine known by the brand name Truvada. The tablets would be taken prior to exposure in an approach known as pre-exposure prophylaxis, or PrEP. Testing a microbicide and PrEP in the same trial will enable scientists to directly compare the two strategies in terms of their safety and acceptability.

The premise behind PrEP is that taking an antiretroviral drug before exposure to HIV could potentially inhibit HIV replication immediately after exposure to the virus, thwarting permanent infection. This strategy is used globally to successfully prevent the transmission of HIV from mother to infant.

Notably, the VOICE study is the first efficacy study of an investigational microbicide in which participants apply the gel once daily rather than shortly before sexual intercourse.

For more information – HIV Information – Talk About HIV

NIAID News gave me permission to share this information with you. I want all of my readers to know what is going on with HIV. Thanks so much for reading my blog.

I am not innocent as some are who also share in the discomfort and in this experience with me. Shamefully I am guilty of sin, many times over, that led to this.

My biggest heartache is the fact that I am a carrier of a contagious disease, but as someone said before, I believe I learned something that until this came along- I had not learned by any other means and that was to fear the Lord.

I have desires just as anyone else, but the fear of the Lord and the sadness that fills my heart of compromising someone else’s health as mine was compromised, hurts me.

When I read that the Lord said that our bodies are his temple and that fornication was the only sin against the body, I began to respect the body of others–but not until I learned I was afflicted. I contracted my disease from my husband just before I married him. Needless to say I sinned.

The word helps me to see how important the body is to the Father. I know you ALL love the Lord as I do and perhaps even more than I. I am so glad that there are some of you who found a man or woman to share your life with. I left my husband, he and his entire family deceived me on several major issues and when confronted, their response was “who cares” it was so early in the marriage that I elected to leave. When I returned home to my family I went to get tested and that’s when I learned there was more. Thankfully I did not sin like that since then.

I am grateful to know that the Lord made provision for me to leave so long as I do not seek anyone else to marry. I think that the Lord is extraordinarily just and merciful.

Please, if you have not found a husband or wife to share your life with and you ask the Lord to bless you, he will. Our circumstances are not all the same as you have seen through the testimonies of others, God knows what is and what is not appropriate-he decides and he gives accordingly.

Remember that he loves you deeply and wants you to make good choices; choices that will help you inherit life forever with him. He loves you so profoundly. Just please understand that his kingdom is very different from the one that deceives the world and we are given the option to chose whom we will love, that we might give him our loyalty as the Righteous King is worthy!

If he were not God, he would not be able to punish anyone. I have not known of any statue or image on the planet that can see everything we do and correct us, not one.

~ Elisa

More Inspirational Stories
Christians With Herpes
More Herpes Information